vs
FOSTER L B CO（FSTR）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
Ultragenyx Pharmaceutical Inc.的季度营收约是FOSTER L B CO的1.3倍（$207.3M vs $160.4M），FOSTER L B CO净利率更高（1.5% vs -62.0%，领先63.5%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs 25.1%），FOSTER L B CO自由现金流更多（$19.8M vs $-100.8M），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs 13.6%）
Foster L B Co.是一家总部位于美国的专业工业制造企业，主要生产销售工程通道产品、建筑组件及铁路基础设施用品，服务覆盖北美及部分全球地区的商业建筑、交通和工业领域客户。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
FSTR vs RARE — 直观对比
营收规模更大
RARE
是对方的1.3倍
$160.4M
营收增速更快
RARE
高出0.8%
25.1%
净利率更高
FSTR
高出63.5%
-62.0%
自由现金流更多
FSTR
多$120.6M
$-100.8M
两年增速更快
RARE
近两年复合增速
13.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $160.4M | $207.3M |
| 净利润 | $2.4M | $-128.6M |
| 毛利率 | 19.7% | — |
| 营业利润率 | 4.9% | -54.7% |
| 净利率 | 1.5% | -62.0% |
| 营收同比 | 25.1% | 25.9% |
| 净利润同比 | 1098.3% | 3.5% |
| 每股收益（稀释后） | $0.22 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FSTRRARE
| Q4 25 | $160.4M | $207.3M | ||
| Q3 25 | $138.3M | $159.9M | ||
| Q2 25 | $143.6M | $166.5M | ||
| Q1 25 | $97.8M | $139.3M | ||
| Q4 24 | $128.2M | $164.6M | ||
| Q3 24 | $137.5M | $139.5M | ||
| Q2 24 | $140.8M | $147.0M | ||
| Q1 24 | $124.3M | $108.8M |
净利润FSTRRARE
| Q4 25 | $2.4M | $-128.6M | ||
| Q3 25 | $4.4M | $-180.4M | ||
| Q2 25 | $2.9M | $-115.0M | ||
| Q1 25 | $-2.1M | $-151.1M | ||
| Q4 24 | $-242.0K | $-133.2M | ||
| Q3 24 | $35.9M | $-133.5M | ||
| Q2 24 | $2.8M | $-131.6M | ||
| Q1 24 | $4.4M | $-170.7M |
毛利率FSTRRARE
| Q4 25 | 19.7% | — | ||
| Q3 25 | 22.5% | — | ||
| Q2 25 | 21.5% | — | ||
| Q1 25 | 20.6% | — | ||
| Q4 24 | 22.3% | — | ||
| Q3 24 | 23.8% | — | ||
| Q2 24 | 21.7% | — | ||
| Q1 24 | 21.1% | — |
营业利润率FSTRRARE
| Q4 25 | 4.9% | -54.7% | ||
| Q3 25 | 6.0% | -106.9% | ||
| Q2 25 | 5.3% | -64.8% | ||
| Q1 25 | -2.0% | -102.6% | ||
| Q4 24 | 2.4% | -74.3% | ||
| Q3 24 | 5.3% | -94.6% | ||
| Q2 24 | 3.2% | -79.1% | ||
| Q1 24 | 4.5% | -151.9% |
净利率FSTRRARE
| Q4 25 | 1.5% | -62.0% | ||
| Q3 25 | 3.1% | -112.8% | ||
| Q2 25 | 2.0% | -69.0% | ||
| Q1 25 | -2.2% | -108.5% | ||
| Q4 24 | -0.2% | -80.9% | ||
| Q3 24 | 26.1% | -95.7% | ||
| Q2 24 | 2.0% | -89.5% | ||
| Q1 24 | 3.6% | -156.8% |
每股收益（稀释后）FSTRRARE
| Q4 25 | $0.22 | $-1.28 | ||
| Q3 25 | $0.40 | $-1.81 | ||
| Q2 25 | $0.27 | $-1.17 | ||
| Q1 25 | $-0.20 | $-1.57 | ||
| Q4 24 | $-0.04 | $-1.34 | ||
| Q3 24 | $3.27 | $-1.40 | ||
| Q2 24 | $0.26 | $-1.52 | ||
| Q1 24 | $0.40 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $4.3M | $421.0M |
| 总债务越低越好 | $42.6M | — |
| 股东权益账面价值 | $175.3M | $-80.0M |
| 总资产 | $330.4M | $1.5B |
| 负债/权益比越低杠杆越低 | 0.24× | — |
8季度趋势，按日历期对齐
现金及短期投资FSTRRARE
| Q4 25 | $4.3M | $421.0M | ||
| Q3 25 | $3.4M | $202.5M | ||
| Q2 25 | $4.2M | $176.3M | ||
| Q1 25 | $2.6M | $127.1M | ||
| Q4 24 | $2.5M | $174.0M | ||
| Q3 24 | $3.1M | $150.6M | ||
| Q2 24 | $4.0M | $480.7M | ||
| Q1 24 | $3.1M | $112.3M |
总债务FSTRRARE
| Q4 25 | $42.6M | — | ||
| Q3 25 | $58.6M | — | ||
| Q2 25 | $81.4M | — | ||
| Q1 25 | $82.3M | — | ||
| Q4 24 | $46.8M | — | ||
| Q3 24 | $68.4M | — | ||
| Q2 24 | $87.0M | — | ||
| Q1 24 | $77.9M | — |
股东权益FSTRRARE
| Q4 25 | $175.3M | $-80.0M | ||
| Q3 25 | $174.8M | $9.2M | ||
| Q2 25 | $174.4M | $151.3M | ||
| Q1 25 | $170.8M | $144.2M | ||
| Q4 24 | $178.3M | $255.0M | ||
| Q3 24 | $181.9M | $346.8M | ||
| Q2 24 | $147.1M | $432.4M | ||
| Q1 24 | $144.6M | $140.3M |
总资产FSTRRARE
| Q4 25 | $330.4M | $1.5B | ||
| Q3 25 | $333.9M | $1.2B | ||
| Q2 25 | $349.9M | $1.3B | ||
| Q1 25 | $342.8M | $1.3B | ||
| Q4 24 | $334.6M | $1.5B | ||
| Q3 24 | $344.5M | $1.5B | ||
| Q2 24 | $333.3M | $1.6B | ||
| Q1 24 | $326.4M | $1.3B |
负债/权益比FSTRRARE
| Q4 25 | 0.24× | — | ||
| Q3 25 | 0.33× | — | ||
| Q2 25 | 0.47× | — | ||
| Q1 25 | 0.48× | — | ||
| Q4 24 | 0.26× | — | ||
| Q3 24 | 0.38× | — | ||
| Q2 24 | 0.59× | — | ||
| Q1 24 | 0.54× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $22.2M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $19.8M | $-100.8M |
| 自由现金流率自由现金流/营收 | 12.3% | -48.6% |
| 资本支出强度资本支出/营收 | 1.5% | 0.5% |
| 现金转化率经营现金流/净利润 | 9.18× | — |
| 过去12个月自由现金流最近4个季度 | $25.2M | $-472.0M |
8季度趋势，按日历期对齐
经营现金流FSTRRARE
| Q4 25 | $22.2M | $-99.8M | ||
| Q3 25 | $29.2M | $-91.4M | ||
| Q2 25 | $10.4M | $-108.3M | ||
| Q1 25 | $-26.1M | $-166.5M | ||
| Q4 24 | $24.3M | $-79.3M | ||
| Q3 24 | $24.7M | $-67.0M | ||
| Q2 24 | $-5.0M | $-77.0M | ||
| Q1 24 | $-21.4M | $-190.7M |
自由现金流FSTRRARE
| Q4 25 | $19.8M | $-100.8M | ||
| Q3 25 | $26.4M | $-92.7M | ||
| Q2 25 | $7.7M | $-110.7M | ||
| Q1 25 | $-28.7M | $-167.8M | ||
| Q4 24 | $22.3M | $-79.5M | ||
| Q3 24 | $21.7M | $-68.6M | ||
| Q2 24 | $-7.0M | $-79.0M | ||
| Q1 24 | $-24.2M | $-193.9M |
自由现金流率FSTRRARE
| Q4 25 | 12.3% | -48.6% | ||
| Q3 25 | 19.1% | -58.0% | ||
| Q2 25 | 5.4% | -66.5% | ||
| Q1 25 | -29.4% | -120.5% | ||
| Q4 24 | 17.4% | -48.3% | ||
| Q3 24 | 15.8% | -49.2% | ||
| Q2 24 | -5.0% | -53.7% | ||
| Q1 24 | -19.4% | -178.2% |
资本支出强度FSTRRARE
| Q4 25 | 1.5% | 0.5% | ||
| Q3 25 | 2.0% | 0.8% | ||
| Q2 25 | 1.9% | 1.5% | ||
| Q1 25 | 2.6% | 1.0% | ||
| Q4 24 | 1.5% | 0.1% | ||
| Q3 24 | 2.2% | 1.2% | ||
| Q2 24 | 1.5% | 1.4% | ||
| Q1 24 | 2.2% | 3.0% |
现金转化率FSTRRARE
| Q4 25 | 9.18× | — | ||
| Q3 25 | 6.70× | — | ||
| Q2 25 | 3.61× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.69× | — | ||
| Q2 24 | -1.74× | — | ||
| Q1 24 | -4.83× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FSTR
| Rail Technologies And Services Segment | $98.0M | 61% |
| Over Time Output Method | $26.3M | 16% |
| Services | $19.4M | 12% |
| Rail Technologies Products | $10.0M | 6% |
| Over Time Input Method | $8.3M | 5% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
